Identification |
Name: | Benzo[a]phenanthridine-10,11-diol,5,6,6a,7,8,12b-hexahydro-, (6aR,12bS)-rel- |
Synonyms: | Benzo[a]phenanthridine-10,11-diol,5,6,6a,7,8,12b-hexahydro-, trans-; Dihydrexidine |
CAS: | 123039-93-0 |
Molecular Formula: | C17H17 N O2 |
Molecular Weight: | 303.78 |
InChI: | InChI=1/C17H17NO2.ClH/c19-15-7-10-5-6-14-17(13(10)8-16(15)20)12-4-2-1-3-11(12)9-18-14;/h1-4,7-8,14,17-20H,5-6,9H2;1H/t14-,17-;/m1./s1 |
Molecular Structure: |
|
Properties |
Flash Point: | 190.5°C |
Boiling Point: | 488.3°Cat760mmHg |
Density: | 1.267g/cm3 |
Biological Activity: | A potent, full efficacy dopamine D 1 agonist which shows no agonist activity at peripheral D 2 receptors or adrenoceptors at doses which cause maximal stimulation of D 1 sites. The compound appears to be fully bioavailable in brain and exhibits profound antiparkinsonism effects in vivo . |
Flash Point: | 190.5°C |
Storage Temperature: | 2-8°C |
Safety Data |
|
|